
FDA Keeps COVID-19 EUA Pipeline Open While Working toward Transition
HHS secretary takes action to ensure that EUAs remain in effect until the “significant potential” for a COVID-19 PHE no longer exists.

HHS secretary takes action to ensure that EUAs remain in effect until the “significant potential” for a COVID-19 PHE no longer exists.

U.S. Department of Health and Human Services secretary takes action to ensure continued access to COVID-19 EUA products.

In the period from Mid-February through mid-March, three different products received first-of-their-kind clearances from the agency.

Companies in the COVID-19 diagnostic products market will need to decide whether to wind down their EUA-based investments.

An overview of what will happen to the COVID-19 tests issued via EUA once the public health emergency ends on May 11.